Table 2.
Clinical characteristics of postchemotherapy neutropenic episodes in the entire patient population
| Characteristic | No. |
|---|---|
| Number of patients | 420 |
| Duration of severe neutropenia, days | |
| Median (range) | 10 (5–30) |
| Neutropenic episodes without infectious symptoms | 187 |
| Neutropenic episodes with extraabdominal infections | 93 |
| Microbiological documented infections | 45 |
| Bacteremia | 43 |
| Gram positive | 25 |
| Coagulase‐negative Staphylococcus | 20 |
| Enterococcus spp. | 5 |
| Gram negative | 18 |
| Eschericia Coli | 10 |
| Pseudomonas spp. | 4 |
| Klebsiella spp. | 4 |
| Fungemia | 2 |
| Candida albicans | 2 |
| Clinically documented infections | 48 |
| Site/source of infection | |
| Upper respiratory tract | 30 |
| Lower respiratory tract | 23 |
| Central venous catheter | 31 |
| Urinary tract | 9 |
| Neutropenic episodes with intraabdominal infections | 140 |
| Microbiological documented infections | 48 |
| Bacteremia | 45 |
| Gram negative | 33 |
| Escherichia Coli | 13 |
| Klebsiella spp. | 9 |
| Bacteroides spp. | 9 |
| Pseudomonas spp. | 2 |
| Gram positive | 12 |
| Enterococcus spp. | 8 |
| Streptococcus spp. | 2 |
| Staphylococcus spp. | 2 |
| Fungemia | 3 |
| Candida albicans | 2 |
| Candida tropicalis | 1 |
| Site/source of infection | |
| Gut | 128 |
| Liver | 5 |
| Gall bladder | 4 |
| Spleen | 3 |
| Abdominal symptoms (plus fever) | 140 |
| Diarrhea | 36 |
| Intestinal bleeding | 29 |
| Abdominal pain | 25 |
| Acute abdomena | 20 |
| Abdominal pain + diarrhea | 15 |
| Septic shocka | 15 |